gem-FYE-broe-zil 
Therapeutic Classification: lipid-lowering agents
Pharmacologic Classification: fibric acid derivatives
Absorption: Well absorbed after oral administration.
Distribution: Unknown.
Metabolism/Excretion: Some metabolism by the liver, 70% excreted by the kidneys (mostly unchanged), 6% excreted in feces.
Half-life: 1.3–1.5 hr.
Contraindicated in:
Use Cautiously in:
Derm: alopecia, rash, urticaria.
EENT: blurred vision.
GI: abdominal pain, diarrhea, epigastric pain, flatulence, gallstones, heartburn, nausea, vomiting.
Hemat: anemia, leukopenia.
MS: myositis.
Neuro: dizziness, headache.
Drug-Drug:
NDC Code*